Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jun
12
2020
CBD Brands Commit to Sponsor Observational Research to Evaluate the Impact of Daily CBD Use on the Liver Function of Healthy Adults Keller and Heckman LLP
Jun
11
2020
Even If the Federal Circuit Could Award Attorney Fees for IPR Appeals, § 285 Does Not Permit It Award Fees Incurred During the IPR Squire Patton Boggs (US) LLP
Jun
11
2020
FMCSA Extends Waiver Period For Certain Pre-Employment Drug Tests From 30 to 90 Days Jackson Lewis P.C.
Jun
11
2020
Pennsylvania Governor Issues Updated Guidance for Hospitality Businesses Conducting In-Person Service Norris McLaughlin P.A.
Jun
11
2020
North American Olive Oil Association Submits Citizen Petition to FDA Asking for Standard of Identity for Olive Oil and Olive-Pomace Oil Keller and Heckman LLP
Jun
10
2020
OTC Monograph Reform: Key Takeaways and What Industry Can Expect Mintz
Jun
10
2020
France Intends to Improve the Identification and Assessment of Manufactured Nanomaterials in Food Bergeson & Campbell, P.C.
Jun
10
2020
Fee Shifting Under § 285 Does Not Apply to Conduct Solely Arising in IPR McDermott Will & Emery
Jun
10
2020
Virginia Enacts “Ban the Box” Legislation for Marijuana Possession Arrests, Charges, and Convictions Hunton Andrews Kurth
Jun
10
2020
Another Federal Judge Dismisses Putative Class Action Over Chocolate-less White Morsels Keller and Heckman LLP
Jun
9
2020
EPA Issues Compliance Advisory Regarding Pesticide Devices Making Claims to Kill the Novel Coronavirus Van Ness Feldman LLP
Jun
9
2020
HRSA Allows 340B Hospitals New Flexibilities to Use 340B Drugs at Offsite Facilities McDermott Will & Emery
Jun
9
2020
Sugar Association Files Citizen Petition Urging Regulatory Changes and Enforcement Action Related to the Labeling of Sugar Substitutes Keller and Heckman LLP
Jun
8
2020
HRSA Poised to Allow 340B Child Sites to Participate Before Appearing on Cost Report Polsinelli PC
Jun
8
2020
Are Qualified Patients Unqualified Parents? University of Missouri School of Law
Jun
8
2020
COVID-19: 340B Update: HRSA Updates Guidance Granting New HOPD Flexibility K&L Gates
Jun
8
2020
NNI Will Hold Webinar on Advances in Self-Powered Wearable Sensors Bergeson & Campbell, P.C.
Jun
8
2020
FDA Updates Policies to Increase Supply of Ethanol Available for Use in Hand Sanitizers Beveridge & Diamond PC
Jun
8
2020
Senate Finance Committee Holds Hearing on FDA’s Foreign Drug Manufacturing Inspection Process Bergeson & Campbell, P.C.
Jun
8
2020
China Newsletter Spring 2020 Direct Investment & Compliance Greenberg Traurig, LLP
Jun
8
2020
FDA Describes “Substantial Progress” Without Providing Any Specific Details on Planned Regulatory Policy for Products Containing CBD Keller and Heckman LLP
Jun
7
2020
Ninth Circuit Vacates EPA’s Renewal of Conditional Registrations for Lower Volatility Dicamba Formulations Bergeson & Campbell, P.C.
Jun
5
2020
HHS Rule is Good News for Prescription Drug Accumulator Programs Hunton Andrews Kurth
Jun
5
2020
EC Extends Timeline for Finalization of Any Proposal for Revision of FCM Legislation to the End of 2022 Keller and Heckman LLP
Jun
5
2020
Update on FDA’s New Era of Smarter Food Safety Initiative in Light of COVID-19 Keller and Heckman LLP
Jun
5
2020
Workshop On Bioanalysis To Be Held By FDA Bergeson & Campbell, P.C.
Jun
5
2020
New CLARITY-BPA Study Examines Low Dose Effect Keller and Heckman LLP
Jun
5
2020
DOE EERE Announces Workshop On Tools To Accelerate Scaling-Up Of Biobased Fuels Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins